Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.
Delphinus Medical Technologies has raised $12.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2023.
Delphinus Medical Technologies's investors include Trinity Capital, Arboretum Ventures, Beringea, Venture Investors, Hopen Life Science Ventures.
Delphinus Medical Technologies is headquartered in Novi, United States.
Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.
Delphinus Medical Technologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Delphinus Medical Technologies — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/delphinus-medical-technologies. Accessed July 20, 2026.
VCBacked. (2023). Delphinus Medical Technologies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/delphinus-medical-technologies
{{cite web |title=Delphinus Medical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/delphinus-medical-technologies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated